No Data
Modalis Therapeutics Reports Positive Foreign Exchange Gains
Modalis Therapeutics: Presentation of financial results for the 3rd quarter of the fiscal year ending 2024/12
Modalis Therapeutics: Summary of Financial Results for the 3rd Quarter Ending 2024/12 [Japanese GAAP] (Consolidated)
Kirin Holdings, shiseido company,limited sponsored adr, Tokyo Metro, NTT (7 days)
※The above calendar is only a schedule and may be subject to change due to company's convenience. ---------------------------------------November 7th (Thu) <1375> Yukiguni Maitake <1382> Hobe <1439> Yasue Construction <147A> Soracom <1515> Nittetsu-ko <1719> Ando Hazama <1720> Tokyu Construction <1738> NITTOH <1788
Tokyo Stock Exchange Gross Index continued to decline, with a lack of buyers ahead of the event.
Tokyo Stock Exchange Growth Market Index 792.98 -1.85 / Volume 0.1 billion 48.76 million shares / Trading value 88.4 billion yen Tokyo Stock Exchange Growth Market 250 Index 618.13 -1.83 / Volume 68.23 million shares / Trading value 68.2 billion yen Today's growth market sees both the Growth Market Index and the Mothers Index continuing to decline, with 252 gainers, 295 decliners, and 37 unchanged. Today's growth market has shown a weak trend. The previous day's Dow Jones Industrial Average in the US market was 257.5.
The TOPIX Growth Market 250 index fell for the first time in 5 days, influenced by the backlash against the recent rise.
The Tokyo Stock Exchange Growth Market Index is 794.83, -12.24 / Volume 0.1 billion 80.83 million shares / Trading value 104.5 billion yen. The Tokyo Stock Exchange Growth Market 250 Index is 619.96, -10.32 / Volume 79.53 million shares / Trading value 78.9 billion yen. Today's growth market, both the Tokyo Stock Exchange Growth Market Index and the Tokyo Stock Exchange Growth Market 250 Index, fell for the first time in 5 days. There were 125 rising issues, 426 declining issues, and 32 unchanged. The US stock market on October 31st continued to decline. The Dow Jones average was down 378.
No Data
No Data